Published in Cell Immunol on October 01, 1977
Dengue virus-induced thymus-derived suppressor cells in the spleen of mice. Immunology (1979) 1.50
Thymus-dependent lymphocytes of dengue virus-infected mice spleens mediate suppression through prostaglandin. Immunology (1981) 1.10
Characterization of the immunosuppression accompanying virus-induced avian osteopetrosis. Infect Immun (1978) 1.07
Depression of vaccinal immunity to Marek's disease by infection with reticuloendotheliosis virus. Infect Immun (1979) 0.84
Subpopulations of suppressor cells in chickens infected with cells of a transplantable lymphoblastic leukemia. Infect Immun (1981) 0.75
Specificity in the immunosuppression induced by avian reticuloendotheliosis virus. Infect Immun (1983) 0.75
Rel-associated pp40: an inhibitor of the rel family of transcription factors. Science (1991) 3.76
The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation. Genes Dev (1991) 3.52
Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity. Proc Natl Acad Sci U S A (1992) 2.29
Nucleotide sequence of v-rel: the oncogene of reticuloendotheliosis virus. Proc Natl Acad Sci U S A (1983) 2.11
Cleavage of a viral envelope precursor during the morphogenesis of Sindbis virus. J Virol (1974) 1.96
Isolation and characterization of reticuloendotheliosis virus transformed bone marrow cells. Intervirology (1974) 1.87
Hematopoietic cell transformation by reticuloendotheliosis virus: characterization of the genetic defect. Virology (1980) 1.73
Specific heterologous enhancement of immune responses. 3. Partial characterization of supernatant material with enhancing activity. J Immunol (1972) 1.58
Relationship of reticuloendotheliosis virus to the avian tumor viruses: nucleic acid and polypeptide composition. J Virol (1973) 1.54
Avian reticuloendotheliosis virus: identification of the hematopoietic target cell for transformation. Cell (1981) 1.49
ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein. Mol Cell Biol (1997) 1.49
Homologous interference induced by Sindbis virus. J Virol (1974) 1.49
Transformation by reticuloendotheliosis virus: development of a focus assay and isolation of a nontransforming virus. Virology (1979) 1.47
Interaction of Sindbis virus glycoproteins during morphogenesis. J Virol (1977) 1.40
Specific heterologous enhancement of immune responses. Proc Natl Acad Sci U S A (1971) 1.37
Correlation of messenger RNA function with adenylate-rich segments in the genomes of single-stranded RNA viruses. Proc Natl Acad Sci U S A (1972) 1.36
Genome of reticuloendotheliosis virus: characterization by use of cloned proviral DNA. J Virol (1982) 1.36
Physiological studies of methane- and methanol-oxidizing bacteria: comparison of a primary alcohol dehydrogenase from Methylococcus capsulatus (Texas strain) and Pseudomonas species M27. J Bacteriol (1972) 1.35
An adenylate-rich segment in the virion RNA of Sindbis virus. Biochem Biophys Res Commun (1972) 1.35
The pharmacokinetics of etanercept in healthy volunteers. Ann Pharmacother (2000) 1.28
Group-specific antigen shared by the members of the reticuloendotheliosis virus complex. J Virol (1976) 1.26
Induction of stress proteins in Sindbis virus- and vesicular stomatitis virus-infected cells. Virology (1983) 1.24
Specific heterologous enhancement of immune responses. V. Isolation of a soluble enhancing factor from supernatants of specifically stimulated and allogeneically induced lymphoid cells. J Immunol (1973) 1.23
Problem-oriented approach to practice. II. Development of the system through audit and implication. JAMA (1977) 1.21
Replication of the reticuloendotheliosis virus (strain T) in chicken embryo cell culture. J Virol (1967) 1.21
Separation of reticuloendotheliosis virus from avian tumor viruses. J Virol (1971) 1.18
Virus-directed post-translational cleavage in Sindbus virus-infected cells. J Virol (1977) 1.17
Patient education through record sharing. QRB Qual Rev Bull (1978) 1.16
Lactobacillus casei-induced polyarthritis in Lewis rats: histopathological scoring system for evaluation of anti-rheumatic drugs. Agents Actions (1991) 1.13
Selective association of Sindbis virion proteins with different membrane fractions of infected cells. J Virol (1972) 1.12
Specific heterologous enhancement of immune responses. II. Immunological memory cells of thymic origin. J Exp Med (1972) 1.11
The v-rel oncogene product is complexed with cellular proteins including its proto-oncogene product and heat shock protein 70. Virology (1990) 1.10
Expression of the oncogene of avian reticuloendotheliosis virus in Escherichia coli and identification of the transforming protein in reticuloendotheliosis virus T-transformed cells. Proc Natl Acad Sci U S A (1986) 1.10
Immunological activity associated with the nucleocapsid and envelope components of an arbovirus. J Virol (1970) 1.08
Transformation of chick embryo fibroblasts by reticuloendotheliosis virus. Virology (1977) 1.08
Phosphorylated proteins of Sindbis virus. J Virol (1974) 1.06
The v-rel oncogene product is complexed to a 40-kDa phosphoprotein in transformed lymphoid cells. Proc Natl Acad Sci U S A (1988) 1.06
RHESUS MONKEYS (MACACA MULATTA) FOR AMERICAN LABORATORIES. Science (1940) 1.03
The transforming protein of avian reticuloendotheliosis virus is a soluble cytoplasmic protein which is associated with a protein kinase activity. Virology (1987) 1.02
Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor. J Immunol (1991) 1.02
The suppression of SH3BGRL is important for v-Rel-mediated transformation. Oncogene (2006) 0.98
AP-1 factors play an important role in transformation induced by the v-rel oncogene. Mol Cell Biol (1998) 0.97
Expression of the v-rel oncogene in reticuloendotheliosis virus-transformed fibroblasts. Virology (1988) 0.97
Specific heterologous enhancement of immune responses. IV. Specific generation of a thymus-derived enhancing factor. J Exp Med (1972) 0.96
Helper viruses associated with avian acute leukemia viruses inhibit the cellular immune response. Virology (1982) 0.96
Alterations within pp59v-rel-containing protein complexes following the stimulation of REV-T-transformed lymphoid cells with zinc. Virology (1992) 0.95
The virus envelope in cell attachment. J Gen Virol (1970) 0.95
Oncogene expression in reticuloendotheliosis virus-transformed lymphoid cell lines and avian tissues. J Virol (1986) 0.94
Identification of protein complexes containing the c-rel proto-oncogene product in avian hematopoietic cells. Oncogene (1990) 0.94
Avian I kappa B alpha is transcriptionally induced by c-Rel and v-Rel with different kinetics. J Virol (1995) 0.94
Alterations in monovalent cation transport in Sindbis virus-infected chick cells. Virology (1984) 0.93
The role of monovalent cation transport in Sindbis virus maturation and release. Virology (1989) 0.93
Immunosuppression induced by avian reticuloendotheliosis virus: mechanism of induction of the suppressor cell. J Immunol (1979) 0.92
Rearrangement and diversification of immunoglobulin light-chain genes in lymphoid cells transformed by reticuloendotheliosis virus. Mol Cell Biol (1989) 0.91
Acquisition of new proviral copies in avian lymphoid cells transformed by reticuloendotheliosis virus. J Virol (1989) 0.90
Interferon regulatory factor 4 contributes to transformation of v-Rel-expressing fibroblasts. Mol Cell Biol (2001) 0.90
Effect of tunicamycin on the development of the cytopathic effect in Sindbis virus-infected avian fibroblasts. Virology (1985) 0.90
Separation of Sindbis virus plaque-type variants by calcium phosphate chromatography. Arch Gesamte Virusforsch (1970) 0.89
Promoting tobacco cessation in the military: an example for primary care providers. Mil Med (1998) 0.88
The v-rel oncogene of avian reticuloendotheliosis virus transforms immature and mature lymphoid cells of the B cell lineage in vitro. Virology (1991) 0.88
The relocalization of v-Rel from the nucleus to the cytoplasm coincides with induction of expression of Ikba and nfkb1 and stabilization of I kappa B-alpha. J Virol (1995) 0.88
Specific heterologous enhancement of immune responses. VI. Partial purification of a nonspecific enhancing factor from supernates of allogeneically stimulated human lymphocyte cell lines. J Exp Med (1974) 0.87
Expression of the c-rel and c-myc proto-oncogenes in avian tissues. Oncogene (1989) 0.87
Transformation of avian fibroblasts overexpressing the c-rel proto-oncogene and a variant of c-rel lacking 40 C-terminal amino acids. J Virol (1994) 0.86
Differences in kappaB DNA-binding properties of v-Rel and c-Rel are the result of oncogenic mutations in three distinct functional regions of the Rel protein. Oncogene (1997) 0.85
Suppression of the mitogen-stimulated blastogenic response during reticuloendotheliosis virus-induced tumorigenesis: investigations into the mechanism of action of the suppressor. J Immunol (1978) 0.85
c-Jun involvement in vitamin E succinate induced apoptosis of reticuloendotheliosis virus transformed avian lymphoid cells. Oncogene (1997) 0.85
Depression of mitogen response in spleen cells from reticuloendotheliosis virus-infected chickens and their suppressive effect on normal lymphocyte response. J Immunol (1978) 0.84
Non-specific suppression of the initiation of the immune response to a heterologous immunogen by supernatants from specifically stimulated, primed lymphoid cells. Immunology (1977) 0.84
Transient suppression of the humoral immune response mediated by a factor derived from specifically activated, doubly primed lymphoid cells. J Immunol (1977) 0.84
Antagonistic interactions between enhancing and suppressor factors that regulate the humoral immune response. Immunology (1979) 0.84
Another way to enhance SOAP's usefulness. Acad Med (1998) 0.83
Degradation of proto-oncoprotein c-Rel by the ubiquitin-proteasome pathway. J Biol Chem (1998) 0.83
Hyperkalemia, verapamil, and dantrolene. Anesthesiology (1987) 0.82
Serine phosphorylation of the v-rel oncogene product/pp40 complex. Biochem Biophys Res Commun (1988) 0.82
Mutations in the DNA-binding and dimerization domains of v-Rel are responsible for altered kappa B DNA-binding complexes in transformed cells. J Virol (1995) 0.82
Synergistic stimulation of avian I kappa B alpha transcription by rel and fos/jun factors. Oncogene (1996) 0.81
T cell products activating stem cells: further studies on the origin and action of the factor(s). J Immunol (1975) 0.81
Identification of a rel-related protein in the nucleus during the S phase of the cell cycle. Mol Cell Biol (1993) 0.80
Assembly of avian reticuloendotheliosis virus: association of the core precursor polypeptide with the intracellular ribonucleoprotein complex. J Virol (1980) 0.80
Protective effects of recombinant human interleukin-1 alpha in doxorubicin-treated normal and tumor-bearing mice. Cancer Res (1993) 0.80
Partial characterization of a T cell-derived factor that suppresses the initiation of the humoral immune response in vitro. Immunology (1977) 0.79
Inhibition of hepatic phosphoenolpyruvate carboxykinase by avian reticuloendotheliosis viruses. Cancer Res (1985) 0.79
Human cutaneous allergic late-phase response is inhibited by soluble IL-1 receptor. J Immunol (1994) 0.79
Characterization of the interaction of reticuloendotheliosis virus with the avian lymphoid system. Cell Immunol (1978) 0.79
Viral oncogenes and signal transduction. Virus Res (1989) 0.79
Purification of two plaque variants of sindbis virus. Arch Gesamte Virusforsch (1970) 0.79
Peptide composition of sindbis virus variants. Arch Gesamte Virusforsch (1970) 0.79
Serum hyaluronate as a marker for disease severity in the Lactobacillus casei model of arthritis in the rat. J Rheumatol (1989) 0.79
Transformation of avian lymphoid cells by reticuloendotheliosis virus. Mutat Res (1988) 0.78
Chicken fetal antigens: role as cell surface receptors for Sindbis virus hemagglutinin. Virology (1980) 0.78
Cell transformation by v-Rel reveals distinct roles of AP-1 family members in Rel/NF-kappaB oncogenesis. Oncogene (2010) 0.78
Isolation and partial characterization of an antibody enhancing factor from leukaemic owl monkey cell cultures. Immunology (1978) 0.78